1. Akaza H, Isaka S, Koiso K, Kotake T, Machida T, Maru A, Matsumura Y, Niijima T, Obata K, Ohe H, Ohi Y, Shimazaki J, Tashiro K, Ueda T, Uyama T, the Japanese Urological Cancer Research Group for Adriamycin (1987) Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Cancer Chemother Pharmacol 20 [Suppl]: S91
2. Fossa SD, Gudmundsen TE (1981) Single drug chemotherapy with 5-FU and Adriamycin in metastatic bladder carcinoma. Br J Urol 53: 320
3. Matsumura Y, Akaza H, Isaka S, Kagawa S, Koiso K, Kotake T, Machida T, Niijima T, Obata K, Ohashi Y, Ohe H, Ohi Y, Shimazaki J, Tashiro K, Ueda T, the Japanese Urological Cancer Research Group for Adriamycin (1992) The 4th study of prophylactic intravesical chemotherapy with Adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese Urological Cancer Research Group for Adriamycin. Cancer Chemother Pharmacol 31 [Suppl]: S10
4. Nagamoto A, Kubota Y, Shuin T, Moriyama M, Satomi Y, Fukushima S, Fukuoka H, Ishizuka E, Furuhata A, Yoshimura S, Matsuura K, Kumagai H, Ida T, Hirokawa M, Nakahashi M, Misaki H, Hosaka M (1989) Phase II study of 5-FU tablets for bladder tumors. Jpn J Cancer Chemother 16: 845
5. Ohmori H, Matsumura Y, Yoshimoto J, Obama T, Hara M, Josen Y, Ishido N, Nasu Y, Tanahashi T, Asai T, Ike N, Akazawa N, Tsushima T, Tanaka H, Furukawa Y (1988) A phase II study of 5-FU tablets for bladder tumors. Jpn J Cancer Chemother 15: 3115